ATV-1601

· Atavistik Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATV-1601, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations [Phase 1]